chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hyperhidrosis, Magnetic resonance imaging abnormal, Nausea, Oropharyngeal pain, Pain
Clinical narrative: After getting the second Moderna vaccine, I felt poorly that evening.  I had symptoms such as: chills, fever, headache , sore throat, nausea, body aches, rash, burning on my hands and feet and shaking.  Later that week,  I experienced profuse sweating and shortness of breath.  On Friday, Feb. 20, 2021, I collapsed.  I had a stroke and couldn't feel my right side.  I was rushed by ambulance to Hospital and admitted under "STROKE ALERT."   The next day I had my second  STROKE which was worse than the first one.  I had to be transported to STROKE CENTER.  I spent about 2 weeks there.  I also had to go to inpatient rehab for PT,OT and Speech Therapy.   I had to work on my balance, walking and gait.  I also had to work on my speech which was difficult.    I have aphasia and the words get misplaced.   My voice gets weak and my words are slurred.  I have been going to outpatient PT, OT  and Speech since I was released from the hospital.  My entire life has been effected and I can't do the things I once could do.  I am unable to drive at the moment and  I am no longer independent.  I am not the same.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, Rash, Speech disorder, Syncope, Tremor
Clinical narrative: After getting the second Moderna vaccine, I felt poorly that evening.  I had symptoms such as: chills, fever, headache , sore throat, nausea, body aches, rash, burning on my hands and feet and shaking.  Later that week,  I experienced profuse sweating and shortness of breath.  On Friday, Feb. 20, 2021, I collapsed.  I had a stroke and couldn't feel my right side.  I was rushed by ambulance to Hospital and admitted under "STROKE ALERT."   The next day I had my second  STROKE which was worse than the first one.  I had to be transported to STROKE CENTER.  I spent about 2 weeks there.  I also had to go to inpatient rehab for PT,OT and Speech Therapy.   I had to work on my balance, walking and gait.  I also had to work on my speech which was difficult.    I have aphasia and the words get misplaced.   My voice gets weak and my words are slurred.  I have been going to outpatient PT, OT  and Speech since I was released from the hospital.  My entire life has been effected and I can't do the things I once could do.  I am unable to drive at the moment and  I am no longer independent.  I am not the same.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Aphasia, Balance disorder, Blood test, Burning sensation, Cerebrovascular accident
Clinical narrative: After getting the second Moderna vaccine, I felt poorly that evening.  I had symptoms such as: chills, fever, headache , sore throat, nausea, body aches, rash, burning on my hands and feet and shaking.  Later that week,  I experienced profuse sweating and shortness of breath.  On Friday, Feb. 20, 2021, I collapsed.  I had a stroke and couldn't feel my right side.  I was rushed by ambulance to Hospital and admitted under "STROKE ALERT."   The next day I had my second  STROKE which was worse than the first one.  I had to be transported to STROKE CENTER.  I spent about 2 weeks there.  I also had to go to inpatient rehab for PT,OT and Speech Therapy.   I had to work on my balance, walking and gait.  I also had to work on my speech which was difficult.    I have aphasia and the words get misplaced.   My voice gets weak and my words are slurred.  I have been going to outpatient PT, OT  and Speech since I was released from the hospital.  My entire life has been effected and I can't do the things I once could do.  I am unable to drive at the moment and  I am no longer independent.  I am not the same.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray, Chills, Computerised tomogram head, Dysarthria, Dysphonia
Clinical narrative: After getting the second Moderna vaccine, I felt poorly that evening.  I had symptoms such as: chills, fever, headache , sore throat, nausea, body aches, rash, burning on my hands and feet and shaking.  Later that week,  I experienced profuse sweating and shortness of breath.  On Friday, Feb. 20, 2021, I collapsed.  I had a stroke and couldn't feel my right side.  I was rushed by ambulance to Hospital and admitted under "STROKE ALERT."   The next day I had my second  STROKE which was worse than the first one.  I had to be transported to STROKE CENTER.  I spent about 2 weeks there.  I also had to go to inpatient rehab for PT,OT and Speech Therapy.   I had to work on my balance, walking and gait.  I also had to work on my speech which was difficult.    I have aphasia and the words get misplaced.   My voice gets weak and my words are slurred.  I have been going to outpatient PT, OT  and Speech since I was released from the hospital.  My entire life has been effected and I can't do the things I once could do.  I am unable to drive at the moment and  I am no longer independent.  I am not the same.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Electrocardiogram, Feeling abnormal, Gait disturbance, Headache
Clinical narrative: After getting the second Moderna vaccine, I felt poorly that evening.  I had symptoms such as: chills, fever, headache , sore throat, nausea, body aches, rash, burning on my hands and feet and shaking.  Later that week,  I experienced profuse sweating and shortness of breath.  On Friday, Feb. 20, 2021, I collapsed.  I had a stroke and couldn't feel my right side.  I was rushed by ambulance to Hospital and admitted under "STROKE ALERT."   The next day I had my second  STROKE which was worse than the first one.  I had to be transported to STROKE CENTER.  I spent about 2 weeks there.  I also had to go to inpatient rehab for PT,OT and Speech Therapy.   I had to work on my balance, walking and gait.  I also had to work on my speech which was difficult.    I have aphasia and the words get misplaced.   My voice gets weak and my words are slurred.  I have been going to outpatient PT, OT  and Speech since I was released from the hospital.  My entire life has been effected and I can't do the things I once could do.  I am unable to drive at the moment and  I am no longer independent.  I am not the same.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hemiparaesthesia, Hyperhidrosis, Impaired driving ability, Loss of personal independence in daily activities, Magnetic resonance imaging head
Clinical narrative: After getting the second Moderna vaccine, I felt poorly that evening.  I had symptoms such as: chills, fever, headache , sore throat, nausea, body aches, rash, burning on my hands and feet and shaking.  Later that week,  I experienced profuse sweating and shortness of breath.  On Friday, Feb. 20, 2021, I collapsed.  I had a stroke and couldn't feel my right side.  I was rushed by ambulance to Hospital and admitted under "STROKE ALERT."   The next day I had my second  STROKE which was worse than the first one.  I had to be transported to STROKE CENTER.  I spent about 2 weeks there.  I also had to go to inpatient rehab for PT,OT and Speech Therapy.   I had to work on my balance, walking and gait.  I also had to work on my speech which was difficult.    I have aphasia and the words get misplaced.   My voice gets weak and my words are slurred.  I have been going to outpatient PT, OT  and Speech since I was released from the hospital.  My entire life has been effected and I can't do the things I once could do.  I am unable to drive at the moment and  I am no longer independent.  I am not the same.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Oropharyngeal pain, Pain, Pyrexia, Rash
Clinical narrative: After getting the second Moderna vaccine, I felt poorly that evening.  I had symptoms such as: chills, fever, headache , sore throat, nausea, body aches, rash, burning on my hands and feet and shaking.  Later that week,  I experienced profuse sweating and shortness of breath.  On Friday, Feb. 20, 2021, I collapsed.  I had a stroke and couldn't feel my right side.  I was rushed by ambulance to Hospital and admitted under "STROKE ALERT."   The next day I had my second  STROKE which was worse than the first one.  I had to be transported to STROKE CENTER.  I spent about 2 weeks there.  I also had to go to inpatient rehab for PT,OT and Speech Therapy.   I had to work on my balance, walking and gait.  I also had to work on my speech which was difficult.    I have aphasia and the words get misplaced.   My voice gets weak and my words are slurred.  I have been going to outpatient PT, OT  and Speech since I was released from the hospital.  My entire life has been effected and I can't do the things I once could do.  I am unable to drive at the moment and  I am no longer independent.  I am not the same.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Skin burning sensation, Speech disorder, Syncope, Thrombectomy, Tremor
Clinical narrative: After getting the second Moderna vaccine, I felt poorly that evening.  I had symptoms such as: chills, fever, headache , sore throat, nausea, body aches, rash, burning on my hands and feet and shaking.  Later that week,  I experienced profuse sweating and shortness of breath.  On Friday, Feb. 20, 2021, I collapsed.  I had a stroke and couldn't feel my right side.  I was rushed by ambulance to Hospital and admitted under "STROKE ALERT."   The next day I had my second  STROKE which was worse than the first one.  I had to be transported to STROKE CENTER.  I spent about 2 weeks there.  I also had to go to inpatient rehab for PT,OT and Speech Therapy.   I had to work on my balance, walking and gait.  I also had to work on my speech which was difficult.    I have aphasia and the words get misplaced.   My voice gets weak and my words are slurred.  I have been going to outpatient PT, OT  and Speech since I was released from the hospital.  My entire life has been effected and I can't do the things I once could do.  I am unable to drive at the moment and  I am no longer independent.  I am not the same.
Age: 19.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Chills, Dehydration, Feeling of body temperature change, Hypoaesthesia
Clinical narrative: when first got the vaccine a fiery numbness went down her arm and now she has some nerve damage she loses strength in her arm
Age: 19.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site pain, Nausea, Neuralgia, Pain in extremity, Pyrexia
Clinical narrative: when first got the vaccine a fiery numbness went down her arm and now she has some nerve damage she loses strength in her arm
Age: 19.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash
Clinical narrative: when first got the vaccine a fiery numbness went down her arm and now she has some nerve damage she loses strength in her arm
Age: 19.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Hypoaesthesia, Nerve injury
Clinical narrative: when first got the vaccine a fiery numbness went down her arm and now she has some nerve damage she loses strength in her arm
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Guillain-Barre syndrome
Clinical narrative: neuropathy, Guillane Barre Syndrome, paresthesia, tingling symmetrical
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Asthenia, Feeling abnormal, Gait disturbance, General physical health deterioration, Guillain-Barre syndrome
Clinical narrative: neuropathy, Guillane Barre Syndrome, paresthesia, tingling symmetrical
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Lumbar puncture abnormal, Mobility decreased
Clinical narrative: neuropathy, Guillane Barre Syndrome, paresthesia, tingling symmetrical
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Guillain-Barre syndrome, Loss of consciousness, Lumbar puncture
Clinical narrative: neuropathy, Guillane Barre Syndrome, paresthesia, tingling symmetrical
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Guillain-Barre syndrome, Neuropathy peripheral, Paraesthesia
Clinical narrative: neuropathy, Guillane Barre Syndrome, paresthesia, tingling symmetrical
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Depression, Gait disturbance, General physical health deterioration, Guillain-Barre syndrome, Myalgia
Clinical narrative: neuropathy, Guillane Barre Syndrome, paresthesia, tingling symmetrical
Age: 89.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Atrial fibrillation, Blood pressure abnormal, Computerised tomogram, Diarrhoea, Endoscopy
Clinical narrative: On March 3rd patient went to Dr. and was transferred by ambulance to hospital . patient was Afib . patient was extremely fatigue. patient had no blood pressure.
Age: 89.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Influenza like illness, Pulmonary embolism, Thrombosis, Vaccination site pain
Clinical narrative: On March 3rd patient went to Dr. and was transferred by ambulance to hospital . patient was Afib . patient was extremely fatigue. patient had no blood pressure.
Age: 89.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Atrial fibrillation, Blood pressure immeasurable, Fatigue
Clinical narrative: On March 3rd patient went to Dr. and was transferred by ambulance to hospital . patient was Afib . patient was extremely fatigue. patient had no blood pressure.
Age: 14.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest pain, Myocarditis, Troponin increased
Clinical narrative: myocarditis
Age: 14.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood calcium normal, Blood chloride normal, Blood creatinine increased, Blood glucose normal, Blood potassium normal
Clinical narrative: myocarditis
Age: 14.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood sodium decreased, Blood urea normal, Carbon dioxide normal, Chest X-ray normal, Chest pain
Clinical narrative: myocarditis
Age: 14.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Echocardiogram, Haematocrit normal, Haemoglobin normal, Headache, Platelet count normal
Clinical narrative: myocarditis
Age: 14.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Tension headache, Troponin increased, White blood cell count increased
Clinical narrative: myocarditis
Age: 14.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Myocarditis, Troponin
Clinical narrative: myocarditis
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Back pain, Computerised tomogram head, Guillain-Barre syndrome, Hypertension
Clinical narrative: generalized weakness at lower extremeties, bilateral fingertip tingling and numbness
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Immunoglobulin therapy, Lumbar puncture abnormal, Magnetic resonance imaging head normal, Magnetic resonance imaging spinal normal
Clinical narrative: generalized weakness at lower extremeties, bilateral fingertip tingling and numbness
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Spinal pain
Clinical narrative: generalized weakness at lower extremeties, bilateral fingertip tingling and numbness
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Lumbar puncture, Muscular weakness, Paraesthesia
Clinical narrative: generalized weakness at lower extremeties, bilateral fingertip tingling and numbness
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Asthenia, COVID-19, Chest X-ray, Decreased activity, SARS-CoV-2 test positive
Clinical narrative: Pt was hospitalized due to COVID -19. Patient is a 70-year-old female with history of hypertension, AFib on Eliquis, interstitial lung disease on home oxygen and DM presenting with increased weakness over the past 4-5 days.  Arrives O2 sat on 2 L 70%; quickly improves when placed on 4 L O2 nasal cannula into the 90s.  She has intermittent tachypnea throughout entire visit otherwise vital signs stable, currently afebrile.  Few isolated readings of hypotension. Rapid COVID positive. Lab evaluation significant for potassium 2.1; provided 40 mEq potassium.  EKG ordered Chest x-ray pending  Discussed with on-call hospitalist who agrees to admit patient for hypokalemia and COVID-19 positive diagnosis.  EKG and chest x-ray yet to be performed.  Request 40 mEq Patient will be admitted to general medicine.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Asthenia, Blood potassium decreased, COVID-19, Hypokalaemia, Hypotension
Clinical narrative: Pt was hospitalized due to COVID -19. Patient is a 70-year-old female with history of hypertension, AFib on Eliquis, interstitial lung disease on home oxygen and DM presenting with increased weakness over the past 4-5 days.  Arrives O2 sat on 2 L 70%; quickly improves when placed on 4 L O2 nasal cannula into the 90s.  She has intermittent tachypnea throughout entire visit otherwise vital signs stable, currently afebrile.  Few isolated readings of hypotension. Rapid COVID positive. Lab evaluation significant for potassium 2.1; provided 40 mEq potassium.  EKG ordered Chest x-ray pending  Discussed with on-call hospitalist who agrees to admit patient for hypokalemia and COVID-19 positive diagnosis.  EKG and chest x-ray yet to be performed.  Request 40 mEq Patient will be admitted to general medicine.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Tachypnoea
Clinical narrative: Pt was hospitalized due to COVID -19. Patient is a 70-year-old female with history of hypertension, AFib on Eliquis, interstitial lung disease on home oxygen and DM presenting with increased weakness over the past 4-5 days.  Arrives O2 sat on 2 L 70%; quickly improves when placed on 4 L O2 nasal cannula into the 90s.  She has intermittent tachypnea throughout entire visit otherwise vital signs stable, currently afebrile.  Few isolated readings of hypotension. Rapid COVID positive. Lab evaluation significant for potassium 2.1; provided 40 mEq potassium.  EKG ordered Chest x-ray pending  Discussed with on-call hospitalist who agrees to admit patient for hypokalemia and COVID-19 positive diagnosis.  EKG and chest x-ray yet to be performed.  Request 40 mEq Patient will be admitted to general medicine.
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: date of first dose 01/27/2021 date of second dose 02/18/2021 patient was transferred to hospital on 08/09/2021 and was tested just prior to transfer was found Covid positive. admitted with encephalopathy (mutifactorial)
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Encephalopathy, SARS-CoV-2 test positive
Clinical narrative: date of first dose 01/27/2021 date of second dose 02/18/2021 patient was transferred to hospital on 08/09/2021 and was tested just prior to transfer was found Covid positive. admitted with encephalopathy (mutifactorial)
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Fatigue, Headache, Heart rate increased, Insomnia
Clinical narrative: FELT ILL FROM THE VACCINE; HEAD SPASMS; TREMORS; RAPID HEARTBEAT; FELT LIKE STROKE/FELT LIKE LEANING TO RIGHT; WEAKNESS; This spontaneous report received from a patient concerned a 58 year old female. The patient's weight was 140 pounds, and height was 65 inches. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A expiry: 23-JUN-2021) dose was not reported, administered on 16-JUN-2021 16:30 for prophylactic vaccination. Concomitant medications included butalbital, methocarbamol, naproxen, paracetamol, prednisone, and venlafaxine. On 17-JUN-2021, the patient experienced felt like stroke/felt like leaning to right. On 17-JUN-2021, the patient experienced weakness. On 23-JUN-2021, the patient experienced tremors. On 23-JUN-2021, the patient experienced rapid heartbeat. On 26-JUN-2021, the patient experienced head spasms. On an unspecified date, the patient experienced felt ill from the vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from tremors, rapid heartbeat, head spasms, felt like stroke/felt like leaning to right, and weakness, and the outcome of felt ill from the vaccine was not reported. This report was non-serious.; Sender's Comments: V0-  Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tremor
Clinical narrative: FELT ILL FROM THE VACCINE; HEAD SPASMS; TREMORS; RAPID HEARTBEAT; FELT LIKE STROKE/FELT LIKE LEANING TO RIGHT; WEAKNESS; This spontaneous report received from a patient concerned a 58 year old female. The patient's weight was 140 pounds, and height was 65 inches. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A expiry: 23-JUN-2021) dose was not reported, administered on 16-JUN-2021 16:30 for prophylactic vaccination. Concomitant medications included butalbital, methocarbamol, naproxen, paracetamol, prednisone, and venlafaxine. On 17-JUN-2021, the patient experienced felt like stroke/felt like leaning to right. On 17-JUN-2021, the patient experienced weakness. On 23-JUN-2021, the patient experienced tremors. On 23-JUN-2021, the patient experienced rapid heartbeat. On 26-JUN-2021, the patient experienced head spasms. On an unspecified date, the patient experienced felt ill from the vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from tremors, rapid heartbeat, head spasms, felt like stroke/felt like leaning to right, and weakness, and the outcome of felt ill from the vaccine was not reported. This report was non-serious.; Sender's Comments: V0-  Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Feeling abnormal, Head discomfort, Heart rate increased, Malaise
Clinical narrative: FELT ILL FROM THE VACCINE; HEAD SPASMS; TREMORS; RAPID HEARTBEAT; FELT LIKE STROKE/FELT LIKE LEANING TO RIGHT; WEAKNESS; This spontaneous report received from a patient concerned a 58 year old female. The patient's weight was 140 pounds, and height was 65 inches. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A expiry: 23-JUN-2021) dose was not reported, administered on 16-JUN-2021 16:30 for prophylactic vaccination. Concomitant medications included butalbital, methocarbamol, naproxen, paracetamol, prednisone, and venlafaxine. On 17-JUN-2021, the patient experienced felt like stroke/felt like leaning to right. On 17-JUN-2021, the patient experienced weakness. On 23-JUN-2021, the patient experienced tremors. On 23-JUN-2021, the patient experienced rapid heartbeat. On 26-JUN-2021, the patient experienced head spasms. On an unspecified date, the patient experienced felt ill from the vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from tremors, rapid heartbeat, head spasms, felt like stroke/felt like leaning to right, and weakness, and the outcome of felt ill from the vaccine was not reported. This report was non-serious.; Sender's Comments: V0-  Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
Age: 89.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: Admitted for COVID 19, presented to ED with weakness, shortness of breath. Currently still undergoing hospital treatment.
Age: 89.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, COVID-19, Dyspnoea
Clinical narrative: Admitted for COVID 19, presented to ED with weakness, shortness of breath. Currently still undergoing hospital treatment.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Burning sensation, Dizziness, Dyskinesia, Loss of consciousness, Pruritus
Clinical narrative: Pt. developed seizure like activity for 1-2 minutes 10 minutes after vaccination. Pt. had convulsions, pallor and some diaphoresis. Was transported to Emergency room via ambulance.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Screaming, Seizure, Sensory disturbance, Skin warm, Speech disorder
Clinical narrative: Pt. developed seizure like activity for 1-2 minutes 10 minutes after vaccination. Pt. had convulsions, pallor and some diaphoresis. Was transported to Emergency room via ambulance.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Syncope
Clinical narrative: Pt. developed seizure like activity for 1-2 minutes 10 minutes after vaccination. Pt. had convulsions, pallor and some diaphoresis. Was transported to Emergency room via ambulance.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hyperhidrosis, Pallor, Seizure, Seizure like phenomena
Clinical narrative: Pt. developed seizure like activity for 1-2 minutes 10 minutes after vaccination. Pt. had convulsions, pallor and some diaphoresis. Was transported to Emergency room via ambulance.
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19 pneumonia, SARS-CoV-2 test
Clinical narrative: SUSPECTED CLINICAL VACCINATION FAILURE; CONFIRMED COVID19 INFECTION; This spontaneous report received from a health care professional concerned multiple patients (2 patients) of unknown race and ethnic origin. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number:1805020, expiry: UNKNOWN) dose was not reported, frequency 1 total, administered on 25-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On an unspecified date, the patient experienced suspected clinical vaccination failure, and confirmed covid-19 infection. Patient had fever, headaches, nasal congestion, and diarrhea. On an unknown date patient had positive COVID-19 tests confirmed by PCR tests. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the suspected clinical vaccination failure and confirmed covid-19 infection was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20210846649 and 20210846822.; Sender's Comments: V0: 20210846435-covid-19 vaccine ad26.cov2.s-Suspected Clinical vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19 pneumonia, Vaccination failure
Clinical narrative: SUSPECTED CLINICAL VACCINATION FAILURE; CONFIRMED COVID19 INFECTION; This spontaneous report received from a health care professional concerned multiple patients (2 patients) of unknown race and ethnic origin. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number:1805020, expiry: UNKNOWN) dose was not reported, frequency 1 total, administered on 25-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On an unspecified date, the patient experienced suspected clinical vaccination failure, and confirmed covid-19 infection. Patient had fever, headaches, nasal congestion, and diarrhea. On an unknown date patient had positive COVID-19 tests confirmed by PCR tests. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the suspected clinical vaccination failure and confirmed covid-19 infection was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20210846649 and 20210846822.; Sender's Comments: V0: 20210846435-covid-19 vaccine ad26.cov2.s-Suspected Clinical vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination failure
Clinical narrative: SUSPECTED CLINICAL VACCINATION FAILURE; CONFIRMED COVID19 INFECTION; This spontaneous report received from a health care professional concerned multiple patients (2 patients) of unknown race and ethnic origin. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number:1805020, expiry: UNKNOWN) dose was not reported, frequency 1 total, administered on 25-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On an unspecified date, the patient experienced suspected clinical vaccination failure, and confirmed covid-19 infection. Patient had fever, headaches, nasal congestion, and diarrhea. On an unknown date patient had positive COVID-19 tests confirmed by PCR tests. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the suspected clinical vaccination failure and confirmed covid-19 infection was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20210846649 and 20210846822.; Sender's Comments: V0: 20210846435-covid-19 vaccine ad26.cov2.s-Suspected Clinical vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angiogram cerebral abnormal, Cerebral disorder, Cerebral venous sinus thrombosis, Computerised tomogram head abnormal
Clinical narrative: DIFFICULTY CONCENTRATING; FELT NAUSEOUS ALL THE TIME; SINUS THROMBOSIS; This spontaneous report received from a patient concerned a 30 year old white female of unspecified ethnic origin. The patient's weight was 230 pounds, and height was 64 inches. The patient was not pregnant at the time of reporting. The patient's concurrent conditions included: not drinking (non alcohol drinker). Other pre-existing medical conditions included: Patient reported no known allergies and had no health issues. Patient was not taking birth control pills for 6 years. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 206A21A, expiry: unknown) dose was not reported, 1 total administered on 02-JUL-2021 at around 14:00 to16:00 pm to left deltoid for prophylactic vaccination. No concomitant medications were reported. On 11-AUG-2021, patient was diagnosed with sinus thrombosis and started with Xarelto 15 mg day for another 1.5 weeks and then increased to 20mg daily. On unspecified date, patient started feeling nauseous all the time and had difficulty in concentrating and stated that it had really affected her life. Patient also stated that the only thing against her was her age and she had her further had scan due. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the sinus thrombosis, felt nauseous all the time and difficulty concentrating was not reported This report was serious (Other Medically Important Condition).; Sender's Comments: V0: This spontaneous report received from a patient concerned a 30-year-old white female of unspecified ethnicity who experienced sinus thrombosis (CVST) 41 days after vaccination.  The patient has no known allergies, no health issues and doesn't drink alcohol. The patient used birth control pills in the past but stopped using them 6 years ago. The patient's concomitant medications and concurrent medications were not reported. At the time of the report the patient was due for an unspecified scan. No lab tests were reported, including platelet count. On day 41, the patient experienced CVST and no relevant information suggesting a diagnosis of thrombosis with thrombocytopenia was reported. Treatment for CVST includes Xarelto 15 mg daily for 1.5 weeks followed by 20 mg daily. On an unspecified date, the patient experienced nausea and difficulty concentrating and stated that it had affected her life. The outcome of the events was not reported. Information is limited in this case, and the occurrence of CVST could represent background incidence of such events in the general population. However, a relationship with Janssen Covid-19 vaccine cannot be ruled out and thus the relationship is considered indeterminate.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cerebral venous sinus thrombosis, Disturbance in attention, Nausea
Clinical narrative: DIFFICULTY CONCENTRATING; FELT NAUSEOUS ALL THE TIME; SINUS THROMBOSIS; This spontaneous report received from a patient concerned a 30 year old white female of unspecified ethnic origin. The patient's weight was 230 pounds, and height was 64 inches. The patient was not pregnant at the time of reporting. The patient's concurrent conditions included: not drinking (non alcohol drinker). Other pre-existing medical conditions included: Patient reported no known allergies and had no health issues. Patient was not taking birth control pills for 6 years. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 206A21A, expiry: unknown) dose was not reported, 1 total administered on 02-JUL-2021 at around 14:00 to16:00 pm to left deltoid for prophylactic vaccination. No concomitant medications were reported. On 11-AUG-2021, patient was diagnosed with sinus thrombosis and started with Xarelto 15 mg day for another 1.5 weeks and then increased to 20mg daily. On unspecified date, patient started feeling nauseous all the time and had difficulty in concentrating and stated that it had really affected her life. Patient also stated that the only thing against her was her age and she had her further had scan due. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the sinus thrombosis, felt nauseous all the time and difficulty concentrating was not reported This report was serious (Other Medically Important Condition).; Sender's Comments: V0: This spontaneous report received from a patient concerned a 30-year-old white female of unspecified ethnicity who experienced sinus thrombosis (CVST) 41 days after vaccination.  The patient has no known allergies, no health issues and doesn't drink alcohol. The patient used birth control pills in the past but stopped using them 6 years ago. The patient's concomitant medications and concurrent medications were not reported. At the time of the report the patient was due for an unspecified scan. No lab tests were reported, including platelet count. On day 41, the patient experienced CVST and no relevant information suggesting a diagnosis of thrombosis with thrombocytopenia was reported. Treatment for CVST includes Xarelto 15 mg daily for 1.5 weeks followed by 20 mg daily. On an unspecified date, the patient experienced nausea and difficulty concentrating and stated that it had affected her life. The outcome of the events was not reported. Information is limited in this case, and the occurrence of CVST could represent background incidence of such events in the general population. However, a relationship with Janssen Covid-19 vaccine cannot be ruled out and thus the relationship is considered indeterminate.
Age: 74.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Interchange of vaccine products, No adverse event
Clinical narrative: INADVERTENTLY RECEIVED THE JANSSEN COVID19 VACCINE AFTER COMPLETION OF MRNA SERIES; This spontaneous report received from a health care professional concerned a 74 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: No known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203A21A expiry: 21-SEP-2021) dose was not reported, administered on 20-AUG-2021 for prophylactic vaccination. Concomitant medications included mRNA 1273 for prophylactic vaccination. On 20-AUG-2021, the patient experienced inadvertently received the Janssen Covid19 vaccine after completion of mRNA series. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of inadvertently received the Janssen Covid19 vaccine after completion of mRNA series. This report was non-serious.
Age: 74.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Medication error
Clinical narrative: INADVERTENTLY RECEIVED THE JANSSEN COVID19 VACCINE AFTER COMPLETION OF MRNA SERIES; This spontaneous report received from a health care professional concerned a 74 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: No known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203A21A expiry: 21-SEP-2021) dose was not reported, administered on 20-AUG-2021 for prophylactic vaccination. Concomitant medications included mRNA 1273 for prophylactic vaccination. On 20-AUG-2021, the patient experienced inadvertently received the Janssen Covid19 vaccine after completion of mRNA series. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of inadvertently received the Janssen Covid19 vaccine after completion of mRNA series. This report was non-serious.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Blood test normal, Computerised tomogram normal, Discomfort, Dizziness
Clinical narrative: Severe persistent headache with blurred vision, fatigue, myalgia and arthralgia, severe photophobia and
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Immediate post-injection reaction, Mobility decreased, Nausea
Clinical narrative: Severe persistent headache with blurred vision, fatigue, myalgia and arthralgia, severe photophobia and
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Photophobia, Pyrexia, Vision blurred
Clinical narrative: Severe persistent headache with blurred vision, fatigue, myalgia and arthralgia, severe photophobia and
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Fatigue, Headache, Myalgia, Photophobia
Clinical narrative: Severe persistent headache with blurred vision, fatigue, myalgia and arthralgia, severe photophobia and
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vision blurred
Clinical narrative: Severe persistent headache with blurred vision, fatigue, myalgia and arthralgia, severe photophobia and
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: C-reactive protein increased, Chest pain, Echocardiogram normal, Electrocardiogram normal, Myocarditis
Clinical narrative: Chest pain, diagnosis peri-myocarditis
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Troponin increased
Clinical narrative: Chest pain, diagnosis peri-myocarditis
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Chest pain, Computerised tomogram, Echocardiogram, Electrocardiogram
Clinical narrative: Chest pain, diagnosis peri-myocarditis
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myocarditis, Scan with contrast
Clinical narrative: Chest pain, diagnosis peri-myocarditis
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Chest X-ray, Respiratory viral panel, SARS-CoV-2 test positive
Clinical narrative: Patient presented to ER with dyspnea after her dialysis. She was diagnosed with COVID pneumonia and is currently still being treated inpatient.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19 pneumonia, Dyspnoea
Clinical narrative: Patient presented to ER with dyspnea after her dialysis. She was diagnosed with COVID pneumonia and is currently still being treated inpatient.
Age: 14.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Back pain, Blood test, Chest X-ray normal, Chest pain, Dyspnoea
Clinical narrative: Chest pain, shortness of breath. Sharp chest pain centrally located, relieved by laying down, worsened by walking. Elevated Troponin levels (Troponin-I :0.67) for concern of vaccine induced myocarditis. Monitored and received Motrin every 8 hours for 24-48 hours . Troponin levels was down trending prior to discharge from ED.   Myocarditis Panel labs sent and are still pending.
Age: 14.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram normal, Headache, Magnetic resonance imaging thoracic normal, Musculoskeletal stiffness, Neck pain
Clinical narrative: Chest pain, shortness of breath. Sharp chest pain centrally located, relieved by laying down, worsened by walking. Elevated Troponin levels (Troponin-I :0.67) for concern of vaccine induced myocarditis. Monitored and received Motrin every 8 hours for 24-48 hours . Troponin levels was down trending prior to discharge from ED.   Myocarditis Panel labs sent and are still pending.
Age: 14.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Troponin T increased, Ultrasound chest, Ultrasound scan normal
Clinical narrative: Chest pain, shortness of breath. Sharp chest pain centrally located, relieved by laying down, worsened by walking. Elevated Troponin levels (Troponin-I :0.67) for concern of vaccine induced myocarditis. Monitored and received Motrin every 8 hours for 24-48 hours . Troponin levels was down trending prior to discharge from ED.   Myocarditis Panel labs sent and are still pending.
Age: 14.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cardiac imaging procedure normal, Chest pain, Dyspnoea, Echocardiogram normal, Electrocardiogram normal
Clinical narrative: Chest pain, shortness of breath. Sharp chest pain centrally located, relieved by laying down, worsened by walking. Elevated Troponin levels (Troponin-I :0.67) for concern of vaccine induced myocarditis. Monitored and received Motrin every 8 hours for 24-48 hours . Troponin levels was down trending prior to discharge from ED.   Myocarditis Panel labs sent and are still pending.
Age: 14.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Laboratory test, Magnetic resonance imaging heart, Troponin I increased
Clinical narrative: Chest pain, shortness of breath. Sharp chest pain centrally located, relieved by laying down, worsened by walking. Elevated Troponin levels (Troponin-I :0.67) for concern of vaccine induced myocarditis. Monitored and received Motrin every 8 hours for 24-48 hours . Troponin levels was down trending prior to discharge from ED.   Myocarditis Panel labs sent and are still pending.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Hyperhidrosis, Loss of consciousness
Clinical narrative: about 10 mins after injection I got light headed and passed out. they called paramedics who came and monitored me for a few minutes then I passed out again they gave me IVs and the epinephrine and then took me by ambulance to a hospital. At the hospital they took blood multiple times and x-rays. after about 8 hours they released me to go home.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood test, Dizziness, Loss of consciousness, X-ray
Clinical narrative: about 10 mins after injection I got light headed and passed out. they called paramedics who came and monitored me for a few minutes then I passed out again they gave me IVs and the epinephrine and then took me by ambulance to a hospital. At the hospital they took blood multiple times and x-rays. after about 8 hours they released me to go home.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Fatigue, Feeling abnormal, Palpitations
Clinical narrative: Return of covid long haul Heart palpitations, chest pain, shortness of breath, fatigue, brain fog
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Post-acute COVID-19 syndrome
Clinical narrative: Return of covid long haul Heart palpitations, chest pain, shortness of breath, fatigue, brain fog
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Arthropod sting, Erythema, Musculoskeletal stiffness, Pain in extremity, Peripheral swelling
Clinical narrative: Approx 24 hours after bee sting in upper left, arm became red and slightly swollen , mostly below (toward the elbow) the sting location.  Swelling progressed toward the elbow and about halfway around the arm.  Total area was slightly larger than my palm.  Area was slightly sore.  (It had not been sore about 6 hours after the sting, and had only a small, dime-sized swelling after the sting.)  Approx 48 hours after the sting, an egg-like swelling occurred below the elbow, without discoloration.  Slightly sore, mostly stiff.  Then the discolored area began to itch.  Swelling gradually subsiding 72 hrs after sting, but itching continues.  I have never had this kind of reaction to a bee sting.  The sting reaction itself appeared to have subsided in the first 4-6 hours, leaving just a tiny red spot with a dark center dot.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Skin discolouration
Clinical narrative: Approx 24 hours after bee sting in upper left, arm became red and slightly swollen , mostly below (toward the elbow) the sting location.  Swelling progressed toward the elbow and about halfway around the arm.  Total area was slightly larger than my palm.  Area was slightly sore.  (It had not been sore about 6 hours after the sting, and had only a small, dime-sized swelling after the sting.)  Approx 48 hours after the sting, an egg-like swelling occurred below the elbow, without discoloration.  Slightly sore, mostly stiff.  Then the discolored area began to itch.  Swelling gradually subsiding 72 hrs after sting, but itching continues.  I have never had this kind of reaction to a bee sting.  The sting reaction itself appeared to have subsided in the first 4-6 hours, leaving just a tiny red spot with a dark center dot.
Age: 23.0
Sex: F
Vaccine: VARCEL
Symptoms: Headache, Nasal congestion, Nasopharyngitis, Rash, Rash erythematous
Clinical narrative: Severe headache the night after vaccination.  Cold symptoms including sinus pain, headache, and nasal congestion for 6 days following vaccination.  Chickenpox-like rash beginning on 6th day after vaccination. Red, raised, itchy bumps started on abdomen and have spread to sides, back, breasts, chest, arms and upper thighs.
Age: 23.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash papular, Rash pruritic, Sinus pain, Varicella
Clinical narrative: Severe headache the night after vaccination.  Cold symptoms including sinus pain, headache, and nasal congestion for 6 days following vaccination.  Chickenpox-like rash beginning on 6th day after vaccination. Red, raised, itchy bumps started on abdomen and have spread to sides, back, breasts, chest, arms and upper thighs.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation irregular
Clinical narrative: Within 4 hours of receiving my second dose of Moderna my period stopped completely. I was on day 2 of my period, which is my heaviest flow day, and I am extremely regular (25 day cycle and 7 day flow for the past 3 years without any birth control). I have never had a 2 day period in my entire life. My next couple of periods took a week longer to arrive.  I am an RN and I do not get my feathers ruffled about many things, but found this to be an abrupt reaction to the vaccine.
Age: 13.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Appendicectomy, Blood test, Computerised tomogram, Flank pain, Pathology test
Clinical narrative: My son got his first dose of the Pfizer Covid-19 Vaccine and five days later he had sharp pains in his side followed by vomiting three times and being in pain all night. I took him to pediatrician in morning and was told to go to the ER where they did an emergency appendectomy on the Tuesday following his vaccine. I am not quite sure if it is a direct result of the vaccine but I did research on the website as well as the University and it states a 1/2500 chance through their testing.